3Purdum PP, Shelden SL, Body JW, et al. Oxaprozin induced fulminant hepatitis. Ann Pharmacother, 1994,28 : 1159-1161.
4Murphy EJ, Daven TJ, Shakil AO, et al. Troglitazone-induced fulminant hepatic failure. Acute liver failure study group. Dig Dis Sci,2000,45:549-553.
5Fontana RJ, Shakil AO, Greenson JK, et al. Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci,2005,50:1785-1790.
6Grieco A, Forgione A, Miele L,et al. Fatty liver and drugs. Eur Rev Med Pharmacol Sci,2005,9:261-263.
7Kuramoto M, Yamane T, Ueno K, et al. A case of fulminant hepatic failure secondary to congestive heart failure. Kokyu To Junkan,1991,39:607-611.
8Baccarani U, Adani GL, Sainz M, et al. Human hepatocyte transplantation for acute liver failure: state of the art and analysis of cell sources. Transplant Proc, 2005,37 : 2702-2704.
2Stange J,Hassanein T I,Mehta R,et al.The MARS as a liver support system based on album in dialysis:a summary of pre-clinical investigations prospective,randomized,controlled clinical trial,and clinical experience from 19 centers[J].Artif Organs,2002,26:103-110.
3Stamler J S,Jaraki O,Osborne J,et al.Nitric oxide circulates in mammalian plasma primarily as an s-nitroso adduct of serum albumin[J].Proc Natl Acad Sci USA,1992,A89:7674-7677.
4Auer I M,Goetz M,Steffen I,et al.In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD)[J].Hepatology,2004,39:1408-1414.
